- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05212974
COVID-19 Vaccine Hesitancy Among Nurses
July 7, 2024 updated by: National Taiwan University Hospital
The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses.
The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination.
The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A cross-sectional study based on convenience samples.
The investigators recruit nurses and the general public to respond to structured self-filling electronic questionnaires by using an electronic data collection system.
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.
Convenience sampling was applied to estimate the sample size according to the number of nurses in each county.
It is planned to collect a total of 4258 responses by the end of the study.
The study instrument is the 5C psychological antecedents of vaccination, which includes Confidence, Complacency, Constraints, Calculation, and Collective Responsibility.
Study Type
Observational
Enrollment (Actual)
4258
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Department of Nursing, National Taiwan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
[Nurses] Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license.
[General publics] Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.
Description
[Nurses]
Inclusion Criteria:
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have verification of registered nurse license.
Exclusion Criteria:
- Male and female participants be>80 years at the time of informed consent.
[General publics]
Inclusion Criteria:
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have reading abilities above the intermediate level.
Exclusion Criteria:
- Male and female participants be>80 years at the time of informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Nurses
Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license.
|
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.
|
|
General publics
Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.
|
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics.
Time Frame: The questionnaire length around 10 minutes.
|
The 5C scale measures the psychological antecedents of vaccination, using 15 item tools including 5 domains (confidence, complacency, constraints, calculation, and collective responsibility).
Each domain was assessed by 3 rating items on a 7-point scale (1=strongly disagree; 7=strongly agree).
The mean scores of items under each domain were computed, with a higher average score indicating stronger agreement of the corresponding domain.
|
The questionnaire length around 10 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jung-Chen Chang, Ph.D, Department of Nursing, National Taiwan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 22, 2022
Primary Completion (Actual)
May 19, 2022
Study Completion (Actual)
May 19, 2022
Study Registration Dates
First Submitted
January 24, 2022
First Submitted That Met QC Criteria
January 24, 2022
First Posted (Actual)
January 28, 2022
Study Record Updates
Last Update Posted (Actual)
July 9, 2024
Last Update Submitted That Met QC Criteria
July 7, 2024
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202106114RINA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University Hospital, ToulouseNot yet recruiting
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
Nova Scotia Health AuthorityNot yet recruitingStroke | Amputation | Spinal Cord Injury | Caregivers | Wheelchair Users | Wheelchair Service ProvidersCanada
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | MetastasisUnited States
-
Centre Hospitalier Universitaire DijonCompleted